Milde-Langosch K - Search Results

1

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

Mahner S, Baasch C, Schwarz J, Hein S, Wölber L, Jänicke F, Milde-Langosch K. Mahner S, et al. Br J Cancer. 2008 Oct 21;99(8):1269-75. doi: 10.1038/sj.bjc.6604650. Br J Cancer. 2008. PMID: 18854825 Free PMC article.

2

p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.

Röhlke P, Milde-Langosch K, Weyland C, Pichlmeier U, Jonat W, Löning T. Röhlke P, et al. J Cancer Res Clin Oncol. 1997;123(9):496-501. doi: 10.1007/BF01192204. J Cancer Res Clin Oncol. 1997. PMID: 9341899

3

Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.

Bamberger AM, Methner C, Lisboa BW, Städtler C, Schulte HM, Löning T, Milde-Langosch K. Bamberger AM, et al. Int J Cancer. 1999 Oct 22;84(5):533-8. doi: 10.1002/(sici)1097-0215(19991022)84:5<533::aid-ijc16>3.0.co;2-j. Int J Cancer. 1999. PMID: 10502734

4

Expression of cell cycle-regulatory proteins rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members.

Milde-Langosch K, Bamberger AM, Methner C, Rieck G, Löning T. Milde-Langosch K, et al. Int J Cancer. 2000 Aug 15;87(4):468-72. Int J Cancer. 2000. PMID: 10918184

5

Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors.

Bamberger AM, Milde-Langosch K, Schulte HM, Löning T. Bamberger AM, et al. Horm Res. 2000;54(1):32-7. doi: 10.1159/000063434. Horm Res. 2000. PMID: 11182633

6

Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.

Milde-Langosch K, Goemann C, Methner C, Rieck G, Bamberger AM, Löning T. Milde-Langosch K, et al. Br J Cancer. 2001 Aug 17;85(4):546-51. doi: 10.1054/bjoc.2001.1923. Br J Cancer. 2001. PMID: 11506494 Free PMC article.

7

Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.

Milde-Langosch K, Bamberger AM, Rieck G, Kelp B, Löning T. Milde-Langosch K, et al. Breast Cancer Res Treat. 2001 May;67(1):61-70. doi: 10.1023/a:1010623308275. Breast Cancer Res Treat. 2001. PMID: 11518467

8

Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters.

Milde-Langosch K, Bamberger AM, Goemann C, Rössing E, Rieck G, Kelp B, Löning T. Milde-Langosch K, et al. J Cancer Res Clin Oncol. 2001 Sep;127(9):537-44. doi: 10.1007/s004320100256. J Cancer Res Clin Oncol. 2001. PMID: 11570574

9

Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators.

Bamberger AM, Milde-Langosch K, Rössing E, Goemann C, Löning T. Bamberger AM, et al. J Cancer Res Clin Oncol. 2001 Sep;127(9):545-50. doi: 10.1007/s004320100255. J Cancer Res Clin Oncol. 2001. PMID: 11570575

10

FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.

Milde-Langosch K, Kappes H, Riethdorf S, Löning T, Bamberger AM. Milde-Langosch K, et al. Breast Cancer Res Treat. 2003 Feb;77(3):265-75. doi: 10.1023/a:1021887100216. Breast Cancer Res Treat. 2003. PMID: 12602926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters